Accumulating evidence suggests that SOX2 promotes cancer cell stemness, and its overexpression is associated with lymph node metastasis and poor prognosis in cancer patients [62]. The gene discussed is SOX2; the disease is metastatic malignant neoplasm in the lymph nodes.